Atossa Therapeutics Inc (NASDAQ:ATOS)

2.44
Delayed Data
As of Sep 25
 +0.13 / +5.63%
Today’s Change
0.76
Today|||52-Week Range
5.08
+55.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues1.8K0.000.000.00
 
 
Cost of Goods Sold132.4K0.000.000.00
 
 
Depreciation And Amortization272.6K303.5K129.0K44.2K
 
 
 
 
 
 
Operating ExpensesGross Income-403.3K-303.5K-129.0K-44.2K
 
 
 
 
 
General Expenses12.4M6.9M7.1M11.4M
 
 
 
 
 
Research And Development2.4M770.4K2.3M4.2M
 
 
 
 
 
Total Operating Expenses12.8M7.2M7.2M11.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.8M-7.2M-7.2M-11.4M
 
 
 
 
 
Extraordinary Credit0.001.8M0.000.00
 
 
Extraordinary Charge0.00-719.0K-742.5K0.00
 
 
 
Interest Expense On Debt--0.00192.8K0.00
 
 
Other Expenses430.00-163.2K150.0029.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.8M-6.4M-8.1M-11.4M
 
 
 
 
 
Preferred Dividend0.000.00-2.6M-11.5M
 
 
 
Discontinued Operations-2.3M0.000.000.00
 
 
Extraordinary Items-670.9K0.000.000.00
 
 
Net Income-15.1M-6.4M-8.1M-11.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS157.9K245.6K974.8K4.2M
 
 
 
 
 
Shares To Calculate EPS Diluted157.9K245.6K974.8K4.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$99.00-$25.92-$10.92-$5.50
 
 
 
 
 
EPS Diluted-$95.54-$25.93-$10.92-$5.50